HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Blood

• Publication date

  2011-07-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2011-02-339275PMID 21551234PMCID PMC3139385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between current level of immunodeficiency and non‐acquired immunodeficiency syndrome‐defining malignancies

  2010cited by this paper
• Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

  2010cited by this paper
• Displacement of T lymphocytes with the 'Helper/Inducer' phenotype from peripheral blood to lymphoid organs in untreated patients with Hodgkin's disease.

  2009cited by this paper
• Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.

  2009cited by this paper
• Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

  2009cited by this paper
• The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC.

  2009cited by this paper
• Hodgkin lymphoma in the Swiss HIV Cohort Study.

  2009cited by this paper
• Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.

  2009cited by this paper
• HIV-associated Hodgkin lymphoma.

  2009cited by this paper
• Incidence and Risk Factors of HIV-Related Non-Hodgkin's Lymphoma in the era of Combination Antiretroviral Therapy: A European Multicohort Study

  2009cited by this paper
• Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy

  2009cited by this paper
• Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

  2008cited by this paper
• Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22

  2008cited by this paper
• Cancer risk in people infected with human immunodeficiency virus in the United States

  2008cited by this paper
• Immunoregulatory T Cells in the Peripheral Blood of Patients with Hodgkin’s Lymphoma

  2006cited by this paper
• Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.

  2006cited by this paper
• Classical Hodgkin’s Lymphoma: Molecular Evidence for Specific Alterations in Circulating T Lymphocytes

  2006cited by this paper
• Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

  2006cited by this paper
• Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study

  2006cited by this paper
• Trends in cancer risk among people with AIDS in the United States 1980–2002

  2006cited by this paper
• Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

  2005cited by this paper
• Immune restoration disease after antiretroviral therapy

  2004cited by this paper
• Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma.

  2004cited by this paper
• Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV

  2004cited by this paper
• Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.

  2003cited by this paper
• Immune Deficiency and Risk for Malignancy Among Persons with AIDS

  2003cited by this paper
• Baseline Predictors of CD4 T‐Lymphocyte Recovery With Combination Antiretroviral Therapy

  2002cited by this paper
• TARC, a CC Chemokine, Is Frequently Expressed in Classic Hodgkin's Lymphoma But Not in NLP Hodgkin's Lymphoma, T-Cell-Rich B-Cell Lymphoma, and Most Cases of Anaplastic Large Cell Lymphoma

  2001cited by this paper
• Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.

  1999cited by this paper
• Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points.

  1999cited by this paper
• Spectrum of AIDS-associated malignant disorders.

  1998cited by this paper
• Expanded European AIDS case definition

  1993cited by this paper
• Expanded European AIDS case definition.

  1993cited by this paper
• Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long‐term follow‐up

  1991cited by this paper

• Estimates of global, regional, and national incidence of Hodgkin lymphoma attributable to Human Immunodeficiency virus: A population attributable modeling study

  2025cites this paper
• Cancer in People with HIV.

  2024cites this paper
• Challenges associated with living with haematological malignancies in sub-Saharan Africa

  2023cites this paper
• Epidemiology and results of the first line therapy for HIV-related Hodgkin lymphoma

  2022cites this paper
• Hodgkin Lymphoma in People Living with HIV

  2021cites this paper
• Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas

  2021cites this paper
• Hematological cancers in individuals infected by HIV.

  2021cites this paper
• Association between Antiretroviral Therapy and Cancers among Children Living with HIV in Sub-Saharan Africa

  2021cites this paper
• Onset of pulmonary Epstein–Barr virus‐positive diffuse large B‐cell lymphoma in a patient with silicosis

  2021cites this paper
• Unmasking lymphoma immune reconstitution inflammatory syndrome in a patient with pyrexia of unknown origin: a case report.

  2020cites this paper
• Human Immunodeficiency Virus (HIV) Infection and Cancer

  2020cites this paper
• HIV‐1, HAART and cancer: A complex relationship

  2020cites this paper
• Spectrum and Incidence Trends of AIDS- and Non–AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort

  2020cites this paper
• The Management of HIV-Hodgkin Lymphoma

  2020cites this paper
• Classic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes

  2020cites this paper
• Complete remission of refractory Hodgkin’s lymphoma in a patient with AIDS after single dose checkpoint inhibitor therapy

  2020influential citation
• Brief Report: HIV-Associated Hodgkin Lymphoma Involving the Bone Marrow Identifies a Very High-Risk Subpopulation in the Era of Widescale Antiretroviral Therapy Use in Johannesburg, South Africa.

  2020cites this paper
• HIV-associated Hodgkin lymphoma involving the bone marrow identifies a very high risk sub-population in the era of widescale Anti-retroviral therapy use in Johannesburg, South Africa.

  2020cites this paper
• Evaluation of prognostic factors affecting long and short term survival rates of Hodgkin's lymphoma patients using the cure fraction models

  2019cites this paper
• Hiv and Lymphoma: from Epidemiology to Clinical Management

  2019influential citation
• Rapid onset of hypercalcemia from high-grade lymphoma in the setting of HIV-related immune reconstitution inflammatory syndrome

  2018cites this paper
• Casual or Causal? Two Unique Cases of Hodgkin’s Lymphoma: A Case Report and Literature Review

  2017cites this paper
• Hodgkin lymphoma, HIV, and Epstein–Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study

  2017cites this paper
• The Role of Cancer Biomarkers in HIV Infected Hosts.

  2016cites this paper
• Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy

  2016cites this paper
• Clinical management of HIV-associated hematologic malignancies

  2016cites this paper
• Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development

  2016cites this paper
• Epstein–Barr Virus Infection and Lymphoproliferative Disorders After Transplantation

  2016cites this paper
• Evolution of HIV-Associated Lymphoma Over 3 Decades

  2016cites this paper
• Hodgkin lymphoma is as common as non‐Hodgkin lymphoma in HIV‐positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study

  2015cites this paper
• The Role of Viral Co-Infection in HIV-Associated Non-AIDS-Related Cancers

  2015cites this paper
• How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

  2015influential citation
• The Epstein–Barr virus and the pathogenesis of lymphoma

  2015cites this paper
• Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity.

  2015cites this paper
• High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.

  2015cites this paper
• Epidemiology and Mechanism of Carcinogenesis of the Retrovirus HIV

  2015cites this paper
• Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.

  2015cites this paper
• Therapy of HIV-associated lymphoma—recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG)

  2014cites this paper
• British HIV Association guidelines for HIV‐associated malignancies 2014

  2014cites this paper
• Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort.

  2014cites this paper
• Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence

  2014cites this paper
• Co-infections, inflammation and oncogenesis: future directions for EBV research.

  2014cites this paper
• Managing HIV and Hodgkin Lymphoma in the Twenty-first century

  2014cites this paper
• Epstein-Barr virus and the origin of Hodgkin lymphoma

  2014cites this paper
• Clinical Characteristics, Incidence, and Risk Factors of HIV-Related Hodgkin Lymphoma in the Era of Combination Antiretroviral Therapy

  2013cites this paper
• Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.

  2013cites this paper
• Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

  2013cites this paper
• Update on the treatment of HIV-associated hematologic malignancies.

  2013cites this paper
• Cancer following combination antiretroviral therapy initiation: Incidence patterns and effects of antiretroviral response

  2013influential citation
• Effect of Immune Reconstitution on the Incidence of HIV-Related Hodgkin Lymphoma

  2013cites this paper
• Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector.

  2013cites this paper
• Children's Oncology Group's 2013 blueprint for research: Adolescent and young adult oncology

  2013cites this paper
• Prevalence of HIV Infection among U.S. Hodgkin Lymphoma Cases

  2013cites this paper
• HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

  2012cites this paper
• Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection

  2012cites this paper
• Role of HIV in Cancer Survival

  2012cites this paper
• Simian virus 40 efficiently infects human T lymphocytes and extends their lifespan.

  2012cites this paper
• Meeting the challenge of hematologic malignancies in sub-Saharan Africa.

  2012cites this paper
• Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan

  2012cites this paper
• HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data

  2011cites this paper
• HIV-assoziierte Lymphome

  2008cites this paper
• Current world literature.

  2006cites this paper